RSV Vaccine Response in Immunocompromised Adults
According to Johns Hopkins Medicine researchers, people 60 years or older with weakened immunity, primarily organ transplant recipients who take
Read MoreAccording to Johns Hopkins Medicine researchers, people 60 years or older with weakened immunity, primarily organ transplant recipients who take
Read MoreUsing shared clinical decision-making, the Advisory Committee on Immunization Practices (ACIP) advised on June 21, 2023, that persons 60 years
Read MoreTwo novel strategies to protect infants from respiratory syncytial virus, or RSV, may soon be accessible in Canada, and a
Read More